Our venture capital fund focuses investments on early-stage life sciences companies looking to improve people’s outcomes with cancer.
Location: United States, Missouri, Saint Louis
Employees: 1-10
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 10
| Date | Name | Website | Total Raised | Location |
| 30.09.2022 | AI Protein... | aiproteins.bio | $18.2M | United Sta... |
| 30.09.2022 | Microbial ... | microbialmachines.com | $3.93M | United Sta... |
| 01.03.2022 | NextRNA Th... | nextrnatx.com | $46.8M | United Sta... |
| - | C4 Therape... | c4therapeutics.com | $243M | United Sta... |
| - | CareVet | carevethealth.com | $228M | United Sta... |
| - | Geneoscopy | geneoscopy.com | $216.9M | United Sta... |
| - | Arch Oncol... | archoncology.com | $155M | United Sta... |
| - | MANA Thera... | manatherapeutics.com | $35M | - |
| - | Simple Ros... | simplerose.com | - | United Sta... |
| - | Wugen | wugen.com | $287M | United Sta... |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Drew | Dennison | Managing D... | linkedin.c... | - | d*******n@... |